TrialThe Journal of infectious diseases2019

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.

Navin Venkatraman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.